VectorY presents 2 posters on the pre-clinical development of VTx-001 and VTx-002 at the American Society of Gene and Cell Therapy Congress 2022 Annual Meeting, May 16-19 in Washington, D.C. May 20 Written By BRONS + TEN KATE Poster #1: VTx-001: VecTabs target Oxidized Phosphatidylcholine for Treating Amyotrophic Lateral Sclerosis (Pasteuning, S et al)Poster #2: VTx-002: VecTabs reduce TDP-43 Pathological Aggregates for Treating Amyotrophic Lateral Sclerosis (Pos, W et al) BRONS + TEN KATE https://www.bronstenkate.com
VectorY presents 2 posters on the pre-clinical development of VTx-001 and VTx-002 at the American Society of Gene and Cell Therapy Congress 2022 Annual Meeting, May 16-19 in Washington, D.C. May 20 Written By BRONS + TEN KATE Poster #1: VTx-001: VecTabs target Oxidized Phosphatidylcholine for Treating Amyotrophic Lateral Sclerosis (Pasteuning, S et al)Poster #2: VTx-002: VecTabs reduce TDP-43 Pathological Aggregates for Treating Amyotrophic Lateral Sclerosis (Pos, W et al) BRONS + TEN KATE https://www.bronstenkate.com
